Illustration of CAR (chimeric antigen receptor) T cell immunotherapy, a process that is being developed to treat cancer. T cells (one at upper left), part of the body's immune system, are taken from the patient and have their DNA (deoxyribonucleic acid) modified by viruses (purple) so that they produce chimeric antigen receptor (CAR) proteins. These proteins will be specific to the patient's cancer. The modified T cells are then multiplied in the laboratory before being reintroduced to the patient.
To submit articles, disclose the results of a research or scientific discoveries write to the editorial staff
Futuroprossimo.it provides news on the future of technology, science and innovation: if there is something that is about to arrive, here it has already arrived. FuturoProssimo is part of the network ForwardTo, studies and skills for future scenarios.
© 2022 Near future -
This work is distributed under license Creative Commons Attribution 4.0 International.